Objective To investigate individual pretreatment serum human chorionic gonadotropin
(hCG) cutoff value for medical treatment success with single-dose and multi-dose regimen of …

Objective To evaluate serum human chorionic gonadotropin (HCG) levels 0–4 days after
single‐dose methotrexate administration for tubal ectopic pregnancy. Methods The present …

Purpose The purpose of this study was to evaluate the initial and day 4 beta-human
chorionic gonadotropin (β-hCG) levels as a predictor of methotrexate (MTX) therapy success …

Aim Methotrexate (MTX) is an efficient treatment for ectopic pregnancy, used according to
'single‐dose'protocol. Treatment success is evaluated on days 4 and 7 after dose …

OBJECTIVE: To assign cutoff values for human chorionic gonadotropin (β-hCG) in
pretreatment and after one methotrexate (MTX) cycle and determine its correspondence to …

Objective To evaluate β‐human chorionic gonadotropin (β‐HCG) level and its 24‐hour
increment as predictors of successful methotrexate treatment for ectopic pregnancy …

Objective To determine whether the success of treatment with single-dose methotrexate (SD
MTX) for ectopic pregnancy can be predicted using the rate of change in serum β-human …

Objective To validate whether change in serum HCG levels between days 0 and 4 confer
any prognostic value during methotrexate therapy and to quantify its change. Study design …

OBJECTIVE: Successful medical management of an ectopic pregnancy is inversely
associated with initial hCG level. The purpose of this publication is to assess whether there …

Study question How effective is the change between day 1 and 4 post-treatment serum hCG
level at predicting single-dose methotrexate treatment success in tubal ectopic pregnancy …